Home›People›Brandon Ingersoll
BI

Brandon Ingersoll

Director at Ratio Therapeutics.

Director
Updated Oct 27, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About Brandon Ingersoll

Brandon Ingersoll is a director at Ratio Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Brandon Ingersoll in the role, so the role may have started earlier or lasted longer.

Ratio Therapeutics, Inc.
Director
2026 · Boston, MA
Develops targeted radioactive medicines for people with cancer.

Key Colleagues at Startups

The people Brandon Ingersoll works with at each company, as listed on that company's latest Form D.

Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
MB
Marc Becker
Chief Financial Officer and Chief Operating Officer
AH
AG
Allan Green
Director
WC
JH
John Hoppin
Chief Executive Officer and director
JB
John Babich
Chief Scientific Officer and director
SW

Sources

  1. SECRatio Therapeutics, Inc. Form D, filed Jul 31, 2026